UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Psoriasiform dermatitis in a person of colour with chronic hepatitis B

JEADV clinical practice, 2024-07, Vol.3 (3), p.882-886

2024

Volltextzugriff (PDF)

Therapie der Psoriasis vulgaris: Therapiestrategien für eine optimale patientenzentrierte Versorgung

Dermatologie (Heidelberg, Germany), 2024-05, Vol.75 (5), p.417-427

2024

Volltextzugriff (PDF)

Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen

Ästhetische Dermatologie & Kosmetologie, 2023-09, Vol.15 (4), p.34-41

2023

Volltextzugriff (PDF)

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists

International journal of women's dermatology, 2023-12, Vol.9 (4), p.e112-e112

2023

Volltextzugriff (PDF)

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Dermatologie (Heidelberg, Germany), 2024-05, Vol.75 (5), p.417-427

2024

Volltextzugriff (PDF)

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Dermatologie (Heidelberg, Germany), 2024-05, Vol.75 (5), p.417

2024

Volltextzugriff (PDF)

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

JAAD international, 2021-03, Vol.2, p.96-97

2021

Volltextzugriff (PDF)

33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB109-AB109

2022

Volltextzugriff (PDF)

Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657

2017

Volltextzugriff (PDF)

Entzündliche Dermatosen im Kindes- und Jugendalter: Diagnostische und therapeutische Besonderheiten anhand der atopischen Dermatitis und der Psoriasis

Dermatologie (Heidelberg, Germany), 2024-04, Vol.75 (4), p.325-339

2024

Volltextzugriff (PDF)

357 The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies

British journal of dermatology (1951), 2023-01, Vol.188 (Supplement_2)

2023

Volltextzugriff (PDF)

43802 Bimekizumab in patients with moderate to severe plaque psoriasis: Injection site reactions through two years of the BE RADIANT phase 3b trial and open-label extension with one-year comparison to secukinumab

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB128-AB128

2023

Volltextzugriff (PDF)

425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB119-AB119

2021

Volltextzugriff (PDF)

Pustulobullous variant of SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657-659

2017

Volltextzugriff (PDF)

Pustulobullöse Variante eines SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657-659

2017

Volltextzugriff (PDF)

Inflammatory dermatoses in children and adolescents : Diagnosis and treatment of atopic dermatitis and psoriasis

Dermatologie (Heidelberg, Germany), 2024-04, Vol.75 (4), p.325-339

2024

Volltextzugriff (PDF)

Erfolgreiche Behandlung einer generalisierten pustulösen Psoriasis mit Certolizumab

Hautarzt, 2021-11, Vol.72 (11), p.992-995

2021

Volltextzugriff (PDF)

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

Dermatology and therapy, 2022-01, Vol.12 (1), p.203-221

2022

Volltextzugriff (PDF)

Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata

Skin (Milwood, N.Y.), 2024-03, Vol.8 (2), p.s394

2024

Volltextzugriff (PDF)

Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s102

2022

Volltextzugriff (PDF)

Extensive coumarin-induced necrosis - a vasculopathy following oral anticoagulation

Journal der Deutschen Dermatologischen Gesellschaft, 2014-03, Vol.12 (3), p.263-264

2014

Volltextzugriff (PDF)

Klinisches Management bei Pruritus

Journal der Deutschen Dermatologischen Gesellschaft, 2015-02, Vol.13 (2), p.101-116

2015

Volltextzugriff (PDF)

Ausgedehnte Cumarinnekrose - eine Vaskulopathie unter oraler Antikoagulation

Journal der Deutschen Dermatologischen Gesellschaft, 2014-03, Vol.12 (3), p.263-264

2014

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaPatients

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Englisch
(21)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Dermatology
(13)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Humans
(6)
Medicine
(5)
Medicine & Public Health
(5)
Diagnosis, Differential
(4)
Allergology
(3)
Immunology
(3)
Proctology
(3)
Psoriasis
(3)
Adult
(2)
Biologics
(2)
Child
(2)
Cme
(2)
Dermatologic Agents - Therapeutic Use
(2)
Effectiveness
(2)
Exanthema
(2)
Inflammatory Skin Diseases
(2)
Original Research
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Psoriasiform dermatitis in a person of colour with chronic hepatitis B

Therapie der Psoriasis vulgaris: Therapiestrategien für eine optimale patientenzentrierte Versorgung

Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema)

Entzündliche Dermatosen im Kindes- und Jugendalter: Diagnostische und therapeutische Besonderheiten anhand der atopischen Dermatitis und der Psoriasis

357 The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies

43802 Bimekizumab in patients with moderate to severe plaque psoriasis: Injection site reactions through two years of the BE RADIANT phase 3b trial and open-label extension with one-year comparison to secukinumab

425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Pustulobullous variant of SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Pustulobullöse Variante eines SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

Inflammatory dermatoses in children and adolescents : Diagnosis and treatment of atopic dermatitis and psoriasis

Erfolgreiche Behandlung einer generalisierten pustulösen Psoriasis mit Certolizumab

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata

Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Extensive coumarin-induced necrosis - a vasculopathy following oral anticoagulation

Klinisches Management bei Pruritus

Ausgedehnte Cumarinnekrose - eine Vaskulopathie unter oraler Antikoagulation

Aktive Filter

Suchergebnisse filtern